Evidence map›Paper›PMID 18821081›Full record

ReviewJournal of neurology2008

Dopamine dysregulation syndrome. Hypothetical application of reward system stimulation for the treatment of anhedonia in Parkinson's disease patients.

Tomoyoshi Kondo

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Journal of neurology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. MPPMolecular neurobiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tomoyoshi KondoDept. of Neurology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-8510, Japan. t-kondo@wakayama-med.ac.jp

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of motor symptoms in Parkinson's disease (PD), although imperfect, has already been standardized. However, patients often spend their time idly despite improvement in the elemental motor symptoms. The main cause of this may be anhedonia. Dopamine dysregulation syndrome (DDS) is a troublesome condition that can occur as a complication of dopamine replacement therapy in PD. As anhedonia and DDS may be converse syndromes in PD patients, it is very important to overcome anhedonia to improve patients' quality of life. In this article, the author proposes the possibility of stimulating patients' desire to participate in physical activity via the incentive of a reward system. Understanding the mechanism of DDS may help in the development of this type of approach.

Indexed as

RewardAgedAntiparkinson AgentsBehavioral SymptomsDopamineDopamine AgonistsFemaleGamblingHumansMaleMiddle AgedMotivationParkinson DiseaseQuality of LifeSubstance-Related DisordersSyndromeAntiparkinson AgentsDopamineDopamine Agonists

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.